0001213900-17-010833.txt : 20171023
0001213900-17-010833.hdr.sgml : 20171023
20171023163833
ACCESSION NUMBER: 0001213900-17-010833
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171020
FILED AS OF DATE: 20171023
DATE AS OF CHANGE: 20171023
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kelly Paul Edward
CENTRAL INDEX KEY: 0001658544
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-55347
FILM NUMBER: 171149274
MAIL ADDRESS:
STREET 1: 300 EAST 56TH STREET, APT 19E
CITY: NEW YORK,
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RELMADA THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001553643
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 455401931
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 275 MADISON AVENUE, SUITE 702
CITY: NEW YORK
STATE: NY
ZIP: 10016
BUSINESS PHONE: 646-677-3853
MAIL ADDRESS:
STREET 1: 275 MADISON AVENUE, SUITE 702
CITY: NEW YORK
STATE: NY
ZIP: 10016
FORMER COMPANY:
FORMER CONFORMED NAME: CAMP NINE, INC.
DATE OF NAME CHANGE: 20120706
4
1
f4101917kelly_relmada.xml
OWNERSHIP DOCUMENT
X0306
4
2017-10-20
0
0001553643
RELMADA THERAPEUTICS, INC.
RLMD
0001658544
Kelly Paul Edward
C/O RELMADA THERAPEUTICS, INC.
750 THIRD AVENUE, 9TH FLOOR
NEW YORK,
NY
10016
1
0
0
0
Options to purchase common stock
0.81
2017-10-20
4
A
0
450000
0.81
A
2027-10-20
Common Stock
450000
450000
D
Pursuant to the terms of the company's 2014 Stock Option and Equity Incentive Plan, 6.25% of the options shall vest each quarter from the date of grant.
/s/ Paul E. Kelly
2017-10-23